Skip to main content
Novartis Home
language-selector-globe Global | en
Choose Location
  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
Global | en
Sandoz | en
Novartis Foundation | en
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Thailand | th
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Slovenia | si
Slovenia | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Egypt | en
Israel | he
Saudi Arabia | ar
South Africa | en
Turkey | tr
language-selector-globe Global
Choose Location
International Americas Asia Pacific Europe Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Global | en
Sandoz | en
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Saudi Arabia | ar
Serbia | sr
Singapore | en
Slovakia | sk
Slovenia | si
Slovenia | en
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Thailand | th
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Board of Directors 
        • Joerg Reinhardt 
        • Simon Moroney 
        • Nancy C. Andrews 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth (Liz) Doherty 
        • Ana de Pro Gonzalo 
        • Bridgette Heller 
        • Daniel Hochstrasser 
        • Frans van Houten 
        • Charles L. Sawyers 
        • William T. Winters 
        • John D. Young 
        • Charlotte Pamer-Wieser 
      • Executive Committee 
        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Klaus Moosmayer 
        • Lutz Hegemann 
        • Mukul Mehta 
        • Kees Roks 
        • Richard Saynor 
        • Michelle Weese 
      • Strategy 
        • People and Culture 
        • Data and Digital 
      • Products 
      • Innovative Medicines 
      • Therapeutic areas 
        • Hematology 
        • Neuroscience 
        • Solid tumors 
      • Sandoz 
      • Diversity, Equity & Inclusion 
        • Equity 
        • Diversity, Equity & Inclusion Governance and Community 
        • Inclusivity 
        • Parental Leave 
        • Society 
      • Manufacturing 
      • Quality 
        • Audit program 
        • Novartis Quality Management System (QMS) 
        • Product and patient safety training 
        • Regulatory inspections 
        • Product recalls 
        • Third-party suppliers 
      • Awards and Recognition 
      Male scientist in lab

      About

      Learn about how Novartis is organized and our strategy, vision and mission. Meet our people and read about our commitments to diversity, equity and inclusion. Explore our history which goes back more than 250 years.

    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Patient Organization Funding 
      • Stories: Patients Perspectives 
      Couple holding hands

      Patients and Caregivers

      Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

    • Healthcare Professionals 
      • Medical Congresses and Events 
        • Abstract summaries for EULAR 
        • Abstract summaries for ACR 
        • ASCO Annual Meeting 
      • Products 
      • Novartis Pipeline 
      • Managed Access Programs 
        • Novartis Gene Therapies Managed Access Program 
      • Novartis External Funding 
      • Healthcare Professional Resources by Country 
      • Investigator-Initiated Trials / Studies 
      • Transparency and Disclosure 
      • Novartis Medical Information 
        • Submit medical enquiry 
      Doctor

      Healthcare Professionals

      Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

    • Research & Development 
      • Novartis Institutes for BioMedical Research 
        • Collaborations 
        • NIBR Global Scholars Program 
      • Technology Platforms 
      • Research Disease Areas 
        • Cardiovascular and metabolic disease research at Novartis 
        • DAx: exploratory disease research at Novartis 
        • Global Health disease area research at Novartis 
        • Immunology disease research at Novartis 
        • Neuroscience research at Novartis 
        • Oncology research at Novartis 
        • Ophthalmology research at Novartis 
      • Novartis Pipeline 
      • Translational Medicine 
      • Research Collaborations 
      • Open Source Science 
      • Stories from our Labs 
      Scientists conducting innovative research experiments

      Research & Development

      Discover how Novartis turns breakthrough science into transformative, high-value treatments.
       

    • ESG 
      • Access 
        • Creating sustainable business models 
        • Value-Based Pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis Access Principles 
        • Novartis Oncology Access 
        • Patents and Licensing 
      • Ethics, Risk and Compliance 
        • Ethical Behavior 
        • Compliance 
        • Human Rights 
        • Learning and Engagement 
        • Risk management 
      • Environmental Sustainability 
        • Climate 
        • Waste 
        • Water 
      • Global Health 
        • Anti-Microbial Resistance (AMR) 
        • Avoidable Blindness 
        • Chagas Disease 
        • Leprosy 
        • Malaria 
        • Sickle Cell Disease (SCD) 
        • Novartis Foundation 
      • Diversity, Equity & Inclusion 
      • Reporting 
        • ESG Rating Performance 
        • Codes, Policies and Guidelines 
        • Materiality Assessment 
        • Transparency and Disclosure 
        • Targets 
        • Positions 
      • ESG Index 
      Young patients waiting outside an hospital in Rwanda

      Environmental, Social and Governance

      Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

    • Investors 
      • Event Calendar 
      • Financial Data 
        • Novartis Annual Results 
        • Novartis Quarterly Results 
        • Novartis SEC Filings 
        • Product Sales 
        • Fixed-Income Securities 
        • Expected Currency Impact 
      • Share Data & Analysis 
        • Share Monitor 
        • Dividend Information 
        • Share Ownership 
        • Share Overview 
        • Return On Investment Calculator 
      • Shareholder Information 
        • General Meetings 
        • American Depository Receipts (ADR) 
        • Share Buy-Back 
        • Frequently Asked Questions 
      • Company Overview 
        • Corporate Governance 
      • Novartis Annual Reporting Suite 
        • Reporting Archive 
        • Publications Order Form 
      • ESG 
      Hands marking a test tube

      Investors

      Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

    • News 
      • News Archive  
      • Media Library  
      • Stories 
      • Subscribe 
      People at the table with screens

      News

      Information for journalists including media releases, statements, stories, multimedia resources and more.

    • Careers 
      • Career Search 
      • Benefits & Rewards 
      • Career Programs 
        • Community Exploration & Learning Lab (CELL) 
        • Postdoc Program 
      • Early Careers 
        • Careers in Data, Digital & Information Technology (IT) 
        • Careers in Technical Operations 
        • Students 
        • Graduates 
        • US NIBR Internship Programs 
      • Personal Growth 
      • Wellbeing 
      Close-up portrait of a scientist in Cambridge, USA

      Careers

      Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

    • Clinical Trials 
      doctor taking the blood pressure of her patient

      Clinical Trials

      Find recruiting clinical trials and learn more about how to participate or work with Novartis on clinical studies. Read about our clinical trials transparency initiatives.

    • Partnering 
      Business people working in a dark room

      Partnering

      Learn about our approach to partnering which combines capabilities, collaboration and culture.

    • Supplier Portal 
      Group of business people in a meeting area

      Supplier Portal

      Practical information and resources for suppliers around the world.

    • Report side effects 
      Our Mission

      Report side effects

      Let us know about any unwanted medical occurrences.

    • Contacts 
      Office Cubicle

      Contacts

      Get in touch.

    Scientist working in a lab

    Home

    Welcome to Novartis where we are reimagining medicine to improve and extend people’s lives.

Stories

Story Navigation
  • All Topics
  • Discovery
  • From Our Labs
  • Patient Perspectives
  • Access to Healthcare
  • People & Culture
icon
  • Scientist at a cell culture hood
    Discovery
    CancerDrug DevelopmentOncologyReimagine Medicine
    Sep 7, 2023
    Treatments for blood cancers and serious blood disorders are advancing rapidly – Novartis is helping lead the way

    Novartis has been at the forefront of advances in how blood cancers and serious blood disorders are treated, helping patients live their best lives.

    Discovery
  • Shiva Malek, Global Head of Oncology at NIBR
    Discovery
    CancerDrug DiscoveryNovartis Institutes for BioMedical ResearchOncologyWomen in Science
    Jun 10, 2022
    A shared mission to take on the “impossible” in cancer research
    Discovery
  • Pediatric CAR-T cell therapy patient
    Discovery
    CancerCell and Gene TherapyChildren's HealthNovartis Institutes for BioMedical ResearchOncology
    May 24, 2022
    How Emily’s act of bravery inspired a wave of continued innovation

    Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.

    Discovery
  • Scientists looking at data on screens
    Discovery
    Biomedical ResearchData ScienceDrug DevelopmentDrug DiscoveryEmerging Technology
    Nov 15, 2021
    The art of drug design in a technological age

    Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

    Discovery
  • stopping this coronavirus and the next one_0
    Discovery
    Biomedical ResearchCOVID-19Drug DiscoveryNovartis Institutes for BioMedical ResearchScientific Research
    Nov 10, 2021
    Stopping this coronavirus – and the next one

    Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

    Discovery
  • Immuno-oncology, a puzzle that needs to be solved
    Discovery
    CancerInnovationScientific ResearchOncology
    Nov 4, 2021
    Solving the puzzle of immunotherapy

    From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.

    Discovery
  • Close-up of an octopus tentacle.
    Discovery
    Drug DiscoveryMusculoskeletal DiseasesScientific ResearchDrug Development
    Oct 1, 2021
    Toward regrowing cartilage

    Novartis researchers aim to improve the lives of patients with osteoarthritis.

    Discovery
  • Trees
    Discovery
    CancerDrug DiscoveryInnovationOncologyScientific Research
    Oct 1, 2021
    The search for new options for patients with lung cancer

    We’re working to bring the hope of advanced medicine to more patients.

    Discovery
  • Artist’s depiction of the inflammasome.
    Discovery
    CancerDiseasesScientific Research
    Oct 1, 2021
    Discover how inflammation could fan the flames of cancer

    Targeting inflammation to fight cancer is a new approach with a long history.

    Discovery
  • RNA strand
    Discovery
    DiseasesScientific ResearchScientific Discoveries
    Sep 27, 2021
    Take a visual tour of medicines that target RNA

    A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

    Discovery
  • A kidney patient is smiling at the camera.
    Discovery
    Living With DiseasePatient VoicesClinical ResearchDrug Development
    Jul 16, 2021
    New hope for treating inflammatory diseases of the kidney

    Novartis researchers aim to preserve kidney function – and quality of life – for patients.

    Discovery
  • 2D rendering of kidneys
    Discovery
    Data ScienceDigitalDrug DiscoveryInnovation
    Jul 16, 2021
    Predictive analytics could bring medicines to patients faster

    Novartis researchers are using data to accelerate drug development.

    Discovery

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 12
  • › Next page

Novartis

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • Researchers
  • Job Seekers
  • Journalists
  • Investors
  • Partners
  • Suppliers
Topics
  • Clinical Trials
  • ESG
  • SpeakUp
Explore
  • Novartis Pipeline
  • Products
  • Therapeutic areas
  • Diseases
  • Stories
  • Locations
Novartis companies
  • Sandoz
  • Advanced Accelerator Applications
  • Chinook Therapeutics
  • Gyroscope Therapeutics
Footer Bottom
© 2023 Novartis AG
  • Terms of Use
  • Privacy
  • Contacts
  • Cookie Settings
  • Site Map
  • Web Accessibility
  • Open Source
Novartis Site Directory
This site is intended for a global audience